MycoTechnology Launches FaaS Platform to Address Commercial Scale Challenges in Bioproducts
US mycelial fermentation company MycoTechnology announces the launch of a Fermentation as a Service (FaaS) platform to help other companies produce bioproducts at a commercial scale, including proteins, enzymes, and probiotics. “Fermentation is a critical process that underpins the production of a wide array of bioproducts,” says Ranjan Patnaik, CTO at MycoTechnology. The new platform offers fermentation capacity services from 300 to 90,000 L. In addition, it provides companies with essential tools and expertise to address commercial production challenges such as product quality, yield, and cost management. Furthermore, the FaaS platform complies with FDA 21 CFR Part 117 guidelines and holds a GFSI audit certification from BRCGS, guaranteeing a “robust and reliable facility for fermentation services,” explains the company. Accelerating innovations MycoTechnology states that this initiative will inspire …